- Home
- Products
- Customized ADCs
- CFD
- Anti-CFD (Lampalizumab)-MC-MMAF ADC
Anti-CFD (Lampalizumab)-MC-MMAF ADC (CAT#: ADC-W-982)
This ADC product is comprised of an anti-CFD monoclonal antibody conjugated via a MC linker to MMAF. The MMAF is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Within the cell, MMAF binds to tubulins, interrupts microtubule dynamics, and subsequently, induces cell death.
- ADC Target
- ADC Antibody
- ADC Linker
- ADC payload drug
- Name
- CFD
- Alternative Names
- CFD; complement factor D (adipsin); D component of complement (adipsin) , DF, PFD, properdin factor D; complement factor D; ADN; properdin factor D; C3 convertase activator; complement factor D preproprotein; D component of complement (adipsin); DF; PFD;
- Target Entrez Gene ID
- 1675
- Target UniProt ID
- P00746
- Overview
- This gene encodes a member of the S1, or chymotrypsin, family of serine peptidases. This protease catalyzes the cleavage of factor B, the rate-limiting step of the alternative pathway of complement activation. This protein also functions as an adipokine,ාܰɫࢸงɵࣛݩɿࣽކʈटຬޣʒूʜ।༛ߜʥআདྷ߹ʯྉࠕʹো࿁࠲˂৭ࡏˌਐု˖ਲၦ࢈˟႞ࢥ˩ვࣂ˳ઙᄌࣟ˼ᅃࣻ̆ᅻघ̐ᆲव̙ଢᇩ॒̣ሠ८̭୧ቘঋ̶உন̀͊ዽৡ͓௰ጵ৾͝ఓ፬ਛͧవᎣਸͰᏚͺ౺ᐑੱ΄ಜᑉಾᒀફΗೡᒷેΡഃᓮΪഥᔦଁδൈᕝଞξ൪ᖔχඌᗋୗϑදᘃ୴ϛෑᘺஐϤෳᙱϮถᚨொϸุᛠ௧Ё๛ఃЋᝎఠЕຟចఽПໂួౚШ៴в༆ᠫಓм༩ᡢರхཋᢚ್яᣑ೩љྐᤈആѢྲണѬ࿔ീѶ൜ѿမ᧥൹҉ျඖғၞᩓඳҜႀාҦႢ᫂෬ҰჅฉҹყᬰฦӃᄉ᭨โӍᄬᮟӖᅎᯖӠᅰᰍນӪᆓ᱅ີӳᆵᱼ໒ӽᇗᲳԇᇺᳪ༌Ԑሜᴢ༨ԚሾᵙཅԤቡᶐརԭኃ᷇ཾԷእ᷿ྛՁወḶྸՊዪṭ࿕ՔጌẤ՞ጯỜဎէፑἓါձ፳Ὂ၈ջ᎖ᾁၤքᎸᾹႁ֎Ꮫ႞֘ᏽ‧Ⴛ֢ᐟ⁞თ֫ᑂₕჴֵᑤᄑֿᒆ℄ᄮᒩ℻ᅊגᓋⅲᅧלᓭ↪ᆄץᔐ⇡ᆡׯᔲ∘ᆽᕔ≏ᇚᕷ⊇ᇷ،ᖙ⊾ሔؖᖻ⋵ሰ؟ᗞ⌬ቍةᘀ⍤ቪسᘢ⎛ኇؼᙅ⏒ኣنᙧ␉ዀِᚉ⑁ዝٙᚬ⑸ዺ٣ᛎ⒯٭ᛰⓦጳٶᜓ┞ፐڀ᜵╕፬
- Overview
- Chimeric Anti-CFD IgG1-kappa-Fab’ fragment , Lampalizumab
- Generic name
- Lampalizumab
- Host animal
- Mouse
- Species Reactivity
- Human
- Name
- MC (maleimidocaproyl)
- Description
- Noncleavable linkers, is considered noncleavable-meaning linker cleavage, and payload release does not depend on the differential properties between the plasma and some cytoplasmic compartments. Instead, the release of the cytotoxic drug is postulated to occur after internalization of the ADC via antigen-mediated endocytosis and delivery to lysosomal compartment, where the antibody is degraded to the level of amino acids through intracellular proteolytic degradation.
- Name
- MMAF
- Description
- Derived from Auristatin,are water-soluble dolastatin analogs of dolastatin 10. Dolastatin 10 belongs to dolastatin family and it can powerfully bind to tubulin, thus inhibiting polymerization mediated through the binding to the vinca alkaloid binding domain, and causes cell to accumulate in metaphase arrest.
For Research Use Only. NOT FOR CLINICAL USE.
Related Products
- Anti-CD3D (Teplizumab)-MC-Vc-PAB-SN38 ADC (CAT#: ADC-W-834)
- Anti-158P1D7 (clone Hal5-10acl2)-VC-MMAE ADC (CAT#: ADC-W-016)
- Anti-LTA (Pateclizumab)-MC-Vc-PAB-SN38 ADC (CAT#: ADC-W-1536)
- Anti-AOC3 (Vapaliximab)-SPDB-DM4 ADC (CAT#: ADC-W-669)
- Anti-IFNA1 (Rontalizumab)-SMCC-DM1 ADC (CAT#: ADC-W-1214)
- Anti-CD22 (Moxetumomab pasudotox)-SPDB-DM4 ADC (CAT#: ADC-W-801)
- Anti-HGF (Flanvotumab)-SPDB-DM4 ADC (CAT#: ADC-W-1191)
- Anti-HGF (Flanvotumab)-MC-MMAF ADC (CAT#: ADC-W-1192)
- Anti-CD37 (Otlertuzumab)-MC-Vc-PAB-SN38 ADC (CAT#: ADC-W-822)
- Anti-GUCY2C (clone 5F9)-Mc-MMAF ADC (CAT#: ADC-W-210)
Published Data
+ Submit Publications
Scientific Resources
Customer Reviews and FAQs
There are currently no Customer reviews or questions for ADC-W-982. Click the button above to contact us or submit your feedback about this product.
Quick Links
Other Products
Same Target
Same Linker
Same Payload
| CAT# | Product Name | Linker | Payload |
| ADC-W-983 | Anti-CFD (Lampalizumab)-MC-Vc-PAB-MMAE ADC | MC-Vc-PAB (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) | MMAE |
| ADC-W-984 | Anti-CFD (Lampalizumab)-MC-Vc-PAB-SN38 ADC | MC-Vc-PAB (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) | SN-38 (7-ethyl-10-hydroxycamptothecin) |
| ADC-W-985 | Anti-CFD (Lampalizumab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC | MC-Vc-PAB-DMEA-(PEG2) | duocarmycin SA |
| ADC-W-980 | Anti-CFD (Lampalizumab)-SMCC-DM1 ADC | SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate) | DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine) |
| ADC-W-981 | Anti-CFD (Lampalizumab)-SPDB-DM4 ADC | SPDB (N-succinimidyl-4-(2-pyridyldithio)butyrate) | DM4 (N2'-Deacetyl-N2'-(4-mercapto-4-methyl-1-oxopentyl)maytansine) |
| CAT# | Product Name | Linker | Payload |
| ADC-W-515 | Anti-EGFR (ABT-806)-Mc-MMAF ADC | Mc (maleimidocaproyl) | MMAF (Monomethyl auristatin F) |
| ADC-W-322 | Anti-CD19 (clone hBU12)-Mc-MMAF ADC | Mc (maleimidocaproyl) | MMAF (Monomethyl auristatin F) |
| ADC-W-517 | Anti-TM4SF1 ( clone v1.10)-Mc-LP2 ADC | Mc (maleimidocaproyl) | LP2 (chemical name mc-3377) |
| ADC-W-491 | Anti-TNFRSF17-Mc-MMAF ADC | Mc (maleimidocaproyl) | MMAF (Monomethyl auristatin F) |
| ADC-W-485 | Anti-EphA2 (clone 1C1)-Mc-MMAF ADC | Mc (maleimidocaproyl) | MMAF (Monomethyl auristatin F) |
| CAT# | Product Name | Linker | Payload |
| ADC-AA-064 | Anti-HIgG(Fab)-C-MMAF ADC | Cleavable linkers | MMAF |
| ADC-AA-063 | Anti-HIgG(Fab)-N-MMAF ADC | Noncleavable linkers | MMAF |
| ADC-W-2579 | Anti-CEACAM5-MC-MMAF ADC | MC (maleimidocaproyl) | MMAF |
| ADC-W-2544 | Anti-CD44 (Bivatuzumab)-MC-MMAF ADC | MC (maleimidocaproyl) | MMAF |
| ADC-W-2573 | Anti-SLC34A2 (Lifastuzumab )-MC-MMAF ADC | MC (maleimidocaproyl) | MMAF |
Online Inquiry
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.
